Research Article
Volume 12 Issue 5 - 2020
How to Avoid or Control Neurological Disorders
Terence C Vardy*
Cambridge University, Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge, UK
*Corresponding Author: Terence C Vardy, Cambridge University, Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge, UK.
Received: April 14, 2020; Published: April 30, 2020




Abstract

Introduction: The world population is ageing and while people are living longer the incidence of neurological degeneration is increasing rapidly..

Objective: There is a critical need to understand the impact of neurological degeneration on society presently and particularly the future impacts. By determining what can be done to ameliorate the symptoms, we may be able to establish better self-management tools to minimize the effects of ageing diseases. Neurological disorders have associated cognitive declines and significant effects on elderly people going about their normal daily living. Medicine and science must also determine and understand if there is an interrelationship between traumatic brain injury and neurodegeneration.

Methods: A review of neurodegenerative diseases including dementia, Parkinson’s disease and Alzheimer’s disease to establish the current incidence and projected patient populations with the associated socioeconomic costs to global communities. Establish if there are pathological commonalities between traumatic brain injury and neurocognitive decline in ageing diseases.

Search Strategy: Medline and Google Scholar searches in addition to the use of personal archives and reference lists from relevant papers in many countries. Evidence Sources: Primary source was empirical papers published in English language journals. Secondary source: Published abstracts of scientific meetings or English abstracts of non‐English journal publications that provide useful information.

Results: Neurological disorders are increasingly rapidly throughout the world and particularly in emerging economies. Less developed nations constitute 52% of the total number of dementia cases worldwide with 46% of these cases in Asia. Females are more susceptible accounting for 59% of the total dementia population. Unfortunately, 70% of the medical costs in 2010 occurred in Western Europe and North America, so medical care and costs are not provided equal to the disease prevalence. Alzheimer’s disease occurs in 70% of dementia patients so the disorders are inseparable. Similarly, 40% of Parkinson’s patients develop dementia as do 44% of mild or moderate traumatic brain injured persons. They all share similarities in pathology with amyloid plaques and neurofibrillary tangles. Avoidance of neurological disorders with ageing is almost impossible depending on how long you live, but there are strategies for minimizing and controlling the effects.

Keywords: Neurological Degeneration; Amyloid Plaques; Neurofibrillary Tangles; Dementia; Alzheimer’s; Parkinson’s disease; medical costs

References

  1. Anders Wiamo., et al. “The worldwide societal costs of dementia: 2009”. Alzheimer's and Dementia2 (2010): 98-103.
  2. Anders Wimoab., et al. “The worldwide economic impact of dementia 2010”. Alzheimer's and Dementia 9 (2013): 111.e3.
  3. Martin Prince., et al. “Recent global trends in the prevalence and incidence of dementia, and survival with dementia Open Access. Alzheimer's Research and Therapy23 (2016): 23.
  4. Alzheimer’s Association. “Alzheimer’s disease facts and figures”. Alzheimer’s and Dementia 11 (2015): 332.
  5. Teresa Gomez-Isla and Matthew P Frosch. “The Challenge of Defining Alzheimer Disease Based on Biomarkers in the Absence of Symptoms”. JAMA Neurology 10 (2019): 1143-1144.
  6. Ron Brookmeyer., et al. “Forecasting the global burden of Alzheimer’s disease”. Alzheimer’s and Dementia3 (2007): 186-191.
  7. Ingelsson M., et al. “Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain”. Neurology6 (2004): 925-931.
  8. Moskalenko YE., et al. “Biomechanical properties of human cranium: Age-relayed aspects”. Journal Evolutionary Biochemical Physiology 44 (2008): 605.
  9. YE Moskalenko., et al. “Changes of Circulatory-Metabolic Indices and Skull Biomechanics with Brain Activity During Aging”. Journal of Integrated Neuroscience10.2 (2011): 131-160.
  10. Yu E Mokalenko., et al. “Quantitative Analysis of Intracranial Volume Slow-Wave Fluctuations” Academic Journal of Life Sciences (2016): 2415-5217.
  11. Walter A Rocca. “The burden of Parkinson’s disease: a worldwide perspective”. The Lancet Neurology11 (2018): 928-929.
  12. Murat Emre., et al. “Clinical diagnostic criteria for dementia associated with Parkinson's disease”. Movement Disorders15 (2007): 1689-1707.
  13. TM Sivanandam., et al. “Traumatic brain injury: a risk factor for Alzheimer's disease”. Neuroscience and Biobehavioral Reviews5 (2012): 1376-1381.
  14. Victoria E Johnson., et al. “Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?” Nature Reviews Neuroscience 11 (2010): 361-370.
  15. Jesse Mez., et al. “Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football”. The Journal of the American Medical Association4 (2017): 360-370.
  16. Peter J Turnbaugh., et al. “The Human Microbiome Project”. Nature 449 (2007): 804-810.
  17. Iliff JJ., et al. “A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β”. Science Translational Medicine147 (2012): 147ra111-147ra111.
  18. Xie L., et al. “Sleep has a critical function in ensuring metabolic homeostasis”. Science 6156 (2013): 373-377.
  19. Xie Lu., et al. “Sleep drives metabolite clearance from the adult brain”. Science6156 (2013): 373-377.
  20. Saper CB., et al. “Sleep state switching”. Neuron 6 (2010): 1023-1042.
  21. Hartmut Wekerle. “The gut–brain connection: triggering of brain autoimmune disease by commensal gut bacteria”. Rheumatology 2 (2016): ii68-ii75.
  22. “Losing our Antimicrobial resistance – The EU’s contribution to the solutions of the global antimicrobial resistance problem”. World Health Organisation. Dr Margaret Chan, Director-General, World Health Organisation. Copenhagen, Denmark (2012).
  23. James J DiNicolantonio., et al. “Sugar addiction: is it real?” A narrative review”. British Journal of Sports Medicine14 (2018): 910-913.
  24. Mitani K. “Relationship between neurological diseases due to aluminium load, especially amyotrophic lateral sclerosis, and magnesium status”. Magnesium Research3 (1992): 203-213.
  25. Johnson ECB., et al. “Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation”. Nature Medicine (2020).
  26. G Raisman. “An urge to explain the Incomprehensible” - Geoffrey Harris and the Discovery of the Neural Control of the Pituitary Gland”. Neuroscience 20 (1997): 533-566.
  27. Mary Lou Galantino., et al. “Association of psychological and physiological measures of stress in health‐care professionals during an 8‐week mindfulness meditation program: mindfulness in practice”. Stress and Health4 (2005).
Citation: Terence C Vardy. “How to Avoid or Control Neurological Disorders”. EC Neurology 12.5 (2020): 73-89.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 15, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk